Mary Beth Terry

Overview

Administrative Titles

  • Co-Leader Cancer Population Sciences, Herbert Irving Comprehensive Cancer Center
  • Associate Director for Community Cancer Prevention, Herbert Irving Comprehensive Cancer Center

Mary Beth Terry, PhD, focuses her research on cancer prevention with a specific focus on breast cancer. She is a cancer epidemiologist with over 20 years of leading studies of cancer etiology specifically focused on the role of genetics, epigenetics, and other biomarkers play in modifying the effects of environmental exposures. Dr. Terry currently leads NIH grants funded through the National Cancer Institute and the National Institute for Environmental Health Sciences that focus on following cancer risk within family-based cohorts focused on studying environmental exposures during key windows of breast cancer susceptibility. She is also leading prospective studies to validate and extend breast cancer risk assessment models. She is also funded through the Breast Cancer Research Foundation. Dr. Terry has authored or co-authored over 300 scientific publications. Her more recent work supports that environmental exposures and biomarkers are associated with modifying risk even within high risk families. Her work also focuses on measuring risk factors for mammographic density, a strong intermediate marker of breast cancer. In addition to her doctorate in epidemiology, Dr. Terry has a Master's degree in economics and previously worked as an econometrician and program evaluator for a number of government-sponsored programs. Dr. Terry teaches introductory and advanced epidemiologic methods.

Credentials & Experience

Education & Training

  • BA, International Affairs, George Washington University
  • MA, Economics, University of Washington, Seattle WA
  • PhD, Epidemiology, Columbia

Honors & Awards

Dean's Excellence in Mentoring Award 2013
CUMC Garvey Academy

Research

Longitudinal Studies, Research Design and Methods, Adolescent Health, Cancer, Cancer Breast, Cancer Screening, Community Programs and Outreach, Disparities / Inequalities in Health, Women's Health, Environmental Epidemiology, Molecular Epidemiology, Genetic Susceptibility, Genetics, Perinatal Epidemiology, Life-course Approach to Prevention

Research Interests

  • Biostatistical Methods
  • Child and Adolescent Health
  • Chronic Disease
  • Community Health
  • Environmental Health
  • Genetics
  • Maternal and Reproductive Health
  • Education

Grants

DNA REPAIR PHENOTYPE THE MISSING LINK IN BREAST CANCER RISK ASSESSMENT (Federal Gov)

Sep 15 2018 - Jun 30 2023

BREAST CANCER FAMILY REGISTRY COHORT (Federal Gov)

May 1 2018 - Apr 30 2023

IMPACT OF BREAST DENSITY INFORMATION DISCLOSURE IN RACIALLY DIVERSE POPULATIONS (Federal Gov)

Sep 1 2016 - May 31 2021

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Jul 1 2016 - May 31 2021

EARLY DETECTION OF OVARIAN CANCER THROUGH EPIGENETIC FACTORS IN THE WHI (Federal Gov)

Mar 8 2016 - Feb 28 2021

INTEGRATING MAMMOGRAMS IN ANALYSES OF GENES AND ENVIRONMENT IN SISTERS (IMAGES) (Federal Gov)

Feb 6 2017 - Jan 31 2021

INCREASING BREAST CANCER CHEMOPREVENTION IN THE PRIMARY CARE SETTING (Federal Gov)

May 1 2014 - Apr 30 2020

DEVELOP QUANTILE ANALYSIS TOOLS FOR SEQUENCING AND EQTL STUDIES (Federal Gov)

May 17 2016 - Feb 29 2020

HOST EPIGENETIC AND MITOCHONDRIAL FUNCTION IN HIV-INFECTED CHILDREN (Federal Gov)

Aug 1 2012 - Jul 31 2019

COORDINATING CENTER FOR THE BREAST CANCER AND THE ENVIRONMENT RESEARCH PROGRAM (Federal Gov)

Oct 1 2018 - Jun 30 2019

CANCER CENTER SUPPORT GRANT (Federal Gov)

Jul 1 2014 - Jun 30 2019

GENES, ENVIRONMENT AND BREAST CANCER RISK: THE 15 YEAR FOLLOW-UP OF THE PROF-SC (TERRY/HOPPER) (Federal Gov)

Jul 1 2011 - Apr 30 2018

BREAST CANCER ACCESS TO CARE AND DISPARITIES RESEARCH PROGRAM (Private)

Jan 1 2017 - Dec 31 2017

BREAST DENSITY PATTERNS AND RISK FACTORS IN AFRICAN IMMIGRANT AND AFRICAN-AMERICAN WOMEN IN NEW YORK (Private)

Oct 1 2015 - Sep 30 2017

TRAINING PROGRAM IN CANCER-RELATED POPULATION SCIENCES (Federal Gov)

Jul 1 2002 - Aug 31 2017

COMPARISON OF BREAST TISSUE CHARACTERISTICS IN WOMEN AND ADOLESCENTS USING OPTICAL SPECTROSCOPY AND (Federal Gov)

Jul 1 2016 - Jun 30 2017

LEGACY: A COHORT OF YOUTH IN FAMILIES FROM THE BREAST CANCER FAMILY REGISTRY (Federal Gov)

Jan 10 2011 - Dec 31 2016

ENVIRONMENTAL EXPOSURES EPIGENETICS AND BREAST CANCER RISK (Private)

Oct 1 2015 - Sep 30 2016

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (UL1) (Federal Gov)

Sep 30 2006 - Jun 30 2016

EPIGENETICS AND RISK FACTORS FOR BREAST AND OVARIAN CANCER IN HIGH RISK WOMEN (TERRY/FERRIS) (Federal Gov)

Apr 1 2014 - May 30 2016

RISK AND PENETRANCE OF MUTATIONS FROM BREAST CANCER TESTING PANELS (Federal Gov)

Jan 1 2015 - Aug 31 2015

PRENATAL ENVIRONMENTAL DETERMINANTS OF INTERGENERATIONAL RIS K (PEDIGREE) (Federal Gov)

Sep 3 2010 - Apr 30 2015

PRENATAL ENVIRONMENTAL DETERMINANTS OF INTERGENERATIONAL RIS K (PEDIGREE) (Federal Gov)

Sep 3 2010 - Apr 30 2015

PRENATAL ENVIRONMENTAL DETERMINANTS OF INTERGENERATIONAL RISK (PEDIGREE) (Federal Gov)

Sep 3 2010 - Apr 30 2015

MULTILEVEL DETERMINANTS OF BREAST DENSITY IN AFRICAN-AMERICAN, HISPANIC AND WHITE WOMEN (Private)

Sep 21 2011 - Sep 20 2014

EPIGENETICS AND DNA REPAIR IN BREAST CANCER RISK (Private)

Oct 1 2012 - Sep 30 2013

EPIGENETICS AND DNA REPAIR IN BREAST CANCER RISK (Private)

Oct 1 2011 - Sep 30 2012

EXPLORING PERSISTENT EPIGENETIC CHANGES AFTER PRENATAL FAMIN E EXPOSURE IN HUMANS (Federal Gov)

Sep 30 2009 - Aug 31 2012

EPIGENETICS AND DNA REPAIR IN BREAST CANCER RISK (Private)

Oct 1 2010 - Sep 30 2011

CANCERS IN OLDER MINORITY POPULATIONS - CARIBBEAN AMERICAN E MPHASIS (Federal Gov)

Sep 26 2003 - Aug 31 2011

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (UL1) (Federal Gov)

Sep 30 2006 - Jun 30 2011

METROPOLITAN NEW YORK REGISTRY OF BREAST CANCER FAMILIES (Federal Gov)

Sep 30 1995 - Jun 30 2011

EARLY DETERMINANTS OF MAMMOGRAPHIC DENSITY (Federal Gov)

Aug 1 2004 - May 31 2011

Selected Publications

Kehm RD, Hopper JL, John EM, Phillips KA, MacInnis RJ, Dite GS, Milne RL, Liao Y, Zeinomar N, Knight JA, Southey MC, Vahdat L, Kornhauser N, Cigler T, Chung WK, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S; kConFab Investigators, Andrulis IL, Buys SS, Daly MB, Terry MB. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. Breast Cancer Res. 2019 Apr 18;21(1):52. doi: 10.1186/s13058-019-1135-y. PMID: 30999962 Free PMC Article

Cohn BA, Cirillo PM, Terry MB. J Natl Cancer Inst. 2019 Feb 13. doi: 10.1093/jnci/djy198. [Epub ahead of print] DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows. PMID: 30759253

Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S, Andrulis IL, John EM, Phillips KA, Daly MB, Buys SS, Hopper JL, MacInnis RJ. 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncol. 2019 Apr;20(4):504-517. doi: 10.1016/S1470-2045(18)30902-1. Epub 2019 Feb 21. PMID: 30799262

Terry MB, Liao Y, Kast K, Antoniou AC, McDonald JA, Mooij TM, Engel C, Nogues C, Buecher B, Mari V, Moretta-Serra J, Gladieff L, Luporsi E, Barrowdale D, Frost D, Henderson A, Brewer C, Evans DG, Eccles D, Cook J, Ong KR, Izatt L, Ahmed M, Morrison PJ, Dommering CJ, Oosterwijk JC, Ausems MGEM, Kriege M, Buys SS, Andrulis IL, John EM, Daly M, Friedlander M, McLachlan SA, Osorio A, Caldes T, Jakubowska A, Simard J, Singer CF, Tan Y, Olah E, Navratilova M, Foretova L, Gerdes AM, Roos-Blom MJ, Arver B, Olsson H, Schmutzler RK, Hopper JL, van Leeuwen FE, Goldgar D, Milne RL, Easton DF, Rookus MA, Andrieu N; EMBRACE, GENEPSO, BCFR, HEBON, kConFab and IBCCS. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations. JNCI Cancer Spectr. 2018 Dec;2(4):pky078. doi: 10.1093/jncics/pky078. Epub 2019 Mar 8.

Shen J, Liao Y, Hopper JL, Goldberg M, Santella RM, Terry MB.Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer.Br J Cancer. 2017 Mar 28. doi: 10.1038/bjc.2017.81

Terry MB, Phillips KA, Daly MB, John EM, Andrulis IL, Buys SS, Goldgar DE, Knight JA, Whittemore AS, Chung WK, Apicella C, Hopper JL. Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC).Int J Epidemiol. 2016 Jun;45(3):683-92. doi: 10.1093/ije/dyv118. Epub 2015 Jul 13.

Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB.Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk. J Natl Cancer Inst. 2015 May 8;107(7). pii: djv124. doi: 10.1093/jnci/djv124. Print 2015 Jul.

Work ME, John EM, Andrulis IL, Knight JA, Liao Y, Mulligan AM, Southey MC, Giles GG, Dite GS, Apicella C, Hibshoosh H, Hopper JL, Terry MB. Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer. 2014 Feb 18. doi: 10.1038/bjc.2013.807. [Epub ahead of print] PMID: 24548865

Terry MB, Wei Y, Esserman D. Maternal, Birth, and Early-Life Influences on Adult Body Size in Women. Am J Epidemiol. 2007; 166(1): 5-13. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk JAMA 291 2433-40 2004